SAMPLE6
Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours. Its proprietary Bioillumination Platform was developed by Professor Tim Lu (MIT) and Dr. Michael Koeris in the lab of Professor James Collins at the Howard Hughes Medical Institute and Boston University. The platform allows for the engineering of bioparticles that target and “light up” specific unwanted bacteria—or specific groups... of bacterial species. They couple this capability with highly sensitive sensor technology that detects low levels of pathogens to see results in minutes—right on-site—with no laboratory required. Sample6′s mission is to improve the health and safety of global consumers by building integrated systems that quickly and easily detect harmful and unwanted bacteria. They see applications in food production, retailing, healthcare, and beyond—anywhere humans and bacteria intersect.
SAMPLE6
Industry:
Biotechnology Health Diagnostics Medical Sensor
Founded:
2009-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.phagediagnostics.com
Total Employee:
11+
Status:
Active
Contact:
617-393-7600
Email Addresses:
[email protected]
Total Funding:
41.7 M USD
Technology used in webpage:
SPF Amazon Virginia Region SingleHop
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Remedy Plan Therapeutics
Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Acre Venture Partners
Acre Venture Partners investment in Series C - Sample6
Valley Oak Investments
Valley Oak Investments investment in Series C - Sample6
Canaan Partners
Canaan Partners investment in Series C - Sample6
Cultivian Sandbox Ventures
Cultivian Sandbox Ventures investment in Series C - Sample6
Timothy K. Lu
Timothy K. Lu investment in Series B - Sample6
Flybridge
Flybridge investment in Series B - Sample6
Flybridge
Flybridge investment in Series B - Sample6
Chevron Technology Ventures
Chevron Technology Ventures investment in Series B - Sample6
Cultivian Sandbox Ventures
Cultivian Sandbox Ventures investment in Series B - Sample6
Founder Collective
Founder Collective investment in Series B - Sample6
Official Site Inspections
http://www.phagediagnostics.com
- Host name: server.iehlabs.com
- IP address: 96.127.129.194
- Location: Chicago United States
- Latitude: 41.8777
- Longitude: -87.6376
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60604
